THERAPEUTICS ACQUISITION COR's ticker is RACA and the CUSIP is 88339T103. A total of 26 filers reported holding THERAPEUTICS ACQUISITION COR in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 350,000 | $4,872,000 | 3.61% |
| Bain Capital Life Sciences Investors, LLC | 1,000,000 | $13,920,000 | 0.87% |
| Boxer Capital, LLC | 1,500,000 | $20,880,000 | 0.67% |
| Logos Global Management LP | 500,000 | $6,960,000 | 0.60% |
| Foresite Capital Management IV, LLC | 350,000 | $4,872,000 | 0.53% |
| BVF INC/IL | 954,996 | $13,322,000 | 0.52% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 39,009 | $543,000 | 0.32% |
| Avoro Capital Advisors LLC | 1,000,000 | $13,950,000 | 0.24% |
| Perceptive Advisors | 1,500,000 | $20,880,000 | 0.22% |
| Cormorant Asset Management, LP | 500,000 | $6,975,000 | 0.17% |